• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial.出版商更正：PREVENT-19新冠疫苗效力临床试验的免疫相关分析
Nat Commun. 2023 Mar 22;14(1):1581. doi: 10.1038/s41467-023-37367-2.
2
Publisher Correction: An immunological autobiography: my year as a COVID-19 vaccine trial participant.出版商更正：一份免疫学自传：我作为新冠疫苗试验参与者的一年。
NPJ Vaccines. 2022 Aug 19;7(1):97. doi: 10.1038/s41541-022-00522-9.
3
Publisher Correction: Use of reliable contraceptives and its correlates among women participating in Simulated HIV vaccine efficacy trials in key-populations in Uganda.出版商更正：乌干达关键人群中参与模拟艾滋病毒疫苗效力试验的女性使用可靠避孕方法及其相关因素。
Sci Rep. 2019 Nov 29;9(1):18274. doi: 10.1038/s41598-019-54660-7.
4
Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial.研究癌症患者接种第三和第四剂 COVID-19 疫苗的免疫反应效果和持久性：一项单臂临床试验。
Elife. 2023 Mar 28;12:e83694. doi: 10.7554/eLife.83694.
5
BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.巴西医护人员的卡介苗再接种以改善针对新冠病毒的先天免疫反应：一项随机对照试验研究方案的结构化总结
Trials. 2020 Oct 26;21(1):881. doi: 10.1186/s13063-020-04822-0.
6
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.评价由科兴中维生产的新型冠状病毒（灭活）疫苗对医护人员的有效性和安全性的双盲、随机、安慰剂对照 III 期临床试验 - PROFISCOV：一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Oct 15;21(1):853. doi: 10.1186/s13063-020-04775-4.
7
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗（灭活，Vero 细胞）有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
8
Correlates of immune and clinical activity of novel cancer vaccines.新型癌症疫苗的免疫和临床活性的相关性。
Semin Immunol. 2018 Oct;39:119-136. doi: 10.1016/j.smim.2018.04.001. Epub 2018 Apr 27.
9
Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up.一种针对新冠病毒的全病毒灭活疫苗QazCovid-in®在健康成年人中的疗效和安全性：一项多中心、随机、单盲、安慰剂对照的3期临床试验，随访6个月。
EClinicalMedicine. 2022 Jun 25;50:101526. doi: 10.1016/j.eclinm.2022.101526. eCollection 2022 Aug.
10
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.基于 rAd26 和 rAd5 载体的异源初免-加强型 COVID-19 疫苗的安全性和有效性：俄罗斯一项随机对照 3 期临床试验的中期分析。
Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2.

引用本文的文献

1
Integrating clinical research into electronic health record workflows to support a learning health system.将临床研究整合到电子健康记录工作流程中，以支持学习型健康系统。
JAMIA Open. 2024 May 15;7(2):ooae023. doi: 10.1093/jamiaopen/ooae023. eCollection 2024 Jul.
2
SARS-CoV-2 Vaccine-Elicited Immunity after B Cell Depletion in Multiple Sclerosis.多发性硬化症患者经 B 细胞耗竭后，SARS-CoV-2 疫苗引发的免疫。
Immunohorizons. 2024 Mar 1;8(3):254-268. doi: 10.4049/immunohorizons.2300108.
3
A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection.一种严重急性呼吸综合征冠状病毒2抗刺突免疫球蛋白G检测：一种利用既定保护关联评估疫苗免疫原性的可靠方法。
Microorganisms. 2023 Jul 11;11(7):1789. doi: 10.3390/microorganisms11071789.

Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial.

作者信息

Fong Youyi, Huang Yunda, Benkeser David, Carpp Lindsay N, Áñez Germán, Woo Wayne, McGarry Alice, Dunkle Lisa M, Cho Iksung, Houchens Christopher R, Martins Karen, Jayashankar Lakshmi, Castellino Flora, Petropoulos Christos J, Leith Andrew, Haugaard Deanne, Webb Bill, Lu Yiwen, Yu Chenchen, Borate Bhavesh, van der Laan Lars W P, Hejazi Nima S, Randhawa April K, Andrasik Michele P, Kublin James G, Hutter Julia, Keshtkar-Jahromi Maryam, Beresnev Tatiana H, Corey Lawrence, Neuzil Kathleen M, Follmann Dean, Ake Julie A, Gay Cynthia L, Kotloff Karen L, Koup Richard A, Donis Ruben O, Gilbert Peter B

机构信息

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

出版信息

Nat Commun. 2023 Mar 22;14(1):1581. doi: 10.1038/s41467-023-37367-2.

DOI:10.1038/s41467-023-37367-2
PMID:36949083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10031713/
Abstract
摘要